Mahsa Faramarzpour

Dr. Mahsa Faramarzpour


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2023 in Nano Energy
Verified
Journal Article
Closed access
MKMohammad Ali Khayamian
Mohammad Ali Khayamian
HAHamed Abadijoo
Hamed Abadijoo
SSShahriar Shalileh
Shahriar Shalileh
MGMohammadreza Ghaderinia
Mohammadreza Ghaderinia
HSHossein Simaee
Hossein Simaee
MAMohammad Abdolahad
Mohammad Abdolahad

27 March 2023 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
MRMasoud Rezaei
Masoud Rezaei
MFMahsa Faramarzpour
Mahsa Faramarzpour
PSParnian Shobeiri
Parnian Shobeiri
HSHoma Seyedmirzaei
Homa Seyedmirzaei
MSMohammad Sharifi Sarasyabi
Mohammad Sharifi Sarasyabi
SDShahriar Dabiri
Shahriar Dabiri
Glaucoma is a chronic neurodegenerative process of the optic nerve that is the leading cause of blindness worldwide, and early diagnosis of the disease could greatly affect patients’ prognoses. The pathophysiology of glaucoma is complicated by a combination of genetic and epigenetic factors. Deciphering the early diagnostic biomarkers in glaucoma could attenuate the disease's global burden and help us understand the exact mechanisms involved in glaucoma. The microRNAs are members of a larger family of non-coding RNAs that play an essential role in the epigenetic basis of glaucoma. A systematic study and meta-analysis of diagnostic microRNAs in glaucoma, jointly with network analysis of target genes, were carried out on published papers assessing differentially expressed microRNAs in human subjects. In total, 321 articles were found, and, after screening, six studies were eligible for further analysis. 52 differentially expressed microRNAs were found, of which 28 and 24 were up-regulated and down-regulated, respectively. Only 12 microRNAs were qualified for meta-analysis, with overall sensitivity and specificity of 80% and 74%, respectively. Then, using network analysis, it became apparent that the VEGF-A, AKT1, CXCL12, and HRAS genes were the most important targets for the microRNAs. Perturbations in WNT signaling, protein transport, and extracellular matrix organization pathways were discovered to be important in the etiology of glaucoma using the community detection approach. This study tries to uncover the promising microRNAs and their target genes that govern the epigenetics of glaucoma.

1 January 2025 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
AKAhmad Khosravi
Ahmad Khosravi
ISIraj Sharifi
Iraj Sharifi
MBMehdi Bamorovat
Mehdi Bamorovat
MPMaryam Parizi
Maryam Parizi
MAMohammad Reza Aflatoonian
Mohammad Reza Aflatoonian
MMMehdi Mohebali
Mehdi Mohebali
Leishmaniasis is an important neglected disease among infectious diseases, which is highly affected by diverse adverse conditions. Due to the intricate nature of Leishmania , the impact of the disease remains significant. In this review, we aim to assess the role of these factors that influence disease trends and introduce preventive and control strategies, highlighting their importance in public health issues. Numerous influencing factors, such as trade and travel, civil unrest, migration, low socioeconomic status, peri‐urban settlements, ecological changes, climate variations, and many other confounding factors, play significant roles in the transmission and distribution of leishmaniasis. On the other hand, inadequate infrastructure and disruptions in the health system services are closely linked with the incidence of leishmaniasis in vulnerable populations. These circumstances contribute to the alteration of vector and reservoir compositions, land degradation, agricultural setbacks, water scarcity, and livestock depletion, resulting in increased infectious and noninfectious disease conditions. In conclusion, significant anthropic and natural environmental changes have the potential to trigger leishmaniasis outbreaks in established endemic areas and lead to the emergence/reemergence of new foci in previously unaffected regions. Consequently, enhancing public health awareness, particularly in high‐risk regions, along with implementing active and passive surveillance, ensuring early diagnosis, and providing timely and effective treatment for patients, are vital measures for controlling the disease.

22 April 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
HEHadi Eslami
Hadi Eslami
SDShahriar Dabiri
Shahriar Dabiri
MFMahsa Faramarzpour
Mahsa Faramarzpour
SZSeyed Ali Hossein Zahraei
Seyed Ali Hossein Zahraei
MZMohammad Hasan Zahraei
Mohammad Hasan Zahraei
Introduction and importance: Cervical area tumors, especially squamous cell carcinoma (SCC), present important clinical challenges, accounting for almost 90% of all head and neck malignancies. Risk factors such as tobacco use, alcohol consumption, and human papillomavirus infection increases the incidence of these malignancies. While SCCs often arise from primary tumors in the oral cavity or other regions, they can also observe in atypical sites like branchial cleft cysts. Case presentation: This report introduces a rare case of SCC arising from a submandibular branchial cleft cyst in a 60-year-old cigarette smoker and opium addict female patient. The patient displayed a progressive mass with no history of malignancy or other problems in the head and neck region. Clinical discussion: Following surgical resection, histopathological observations confirmed SCC within the branchial cleft cyst, indicating a rare malignant transformation. Notably, the primary source of SCC remains undetermined despite comprehensive evaluations. Conclusion: Although branchial cleft cysts are typically benign, this case underscores the importance of careful assessment of neck masses in patients with risk factors for malignancy, to facilitate early diagnosis and optimal management of this uncommon presentation of SCC.

8 June 2026 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
NKNavid Moshtaghi Kashanian
Navid Moshtaghi Kashanian
HNHanieh Niroomand-Oscuii
Hanieh Niroomand-Oscuii
SDShahriar Dabiri
Shahriar Dabiri
NMNarges Meghdadi
Narges Meghdadi
MEMasoud Eslami
Masoud Eslami
MFMahsa Faramarzpour
Mahsa Faramarzpour
Objective: Glioblastoma exhibits highly heterogeneous growth and infiltration patterns, limiting the predictive value of routine imaging and population-averaged tumor growth models. This study aimed to develop a clinically feasible, biomarker-informed reaction–diffusion framework that integrates standard magnetic resonance imaging with routinely available immunohistochemical markers to support patient-specific modeling of glioblastoma growth. Approach: A reaction–diffusion model was formulated using standard clinical MRI sequences, including contrast-enhanced T1-weighted and T2-weighted images, together with immunohistochemical biomarkers, particularly the antigen protein (Ki-67) and Isocitrate dehydrogenase 1 (IDH-1) status. Baseline diffusion and proliferation parameters were estimated from MRI-derived growth metrics. A pathological coefficient was introduced as a biologically interpretable modifier of the proliferation term to incorporate microscopic tumor aggressiveness into the macroscopic growth model. The coefficient was identified through constrained inverse parameter estimation and subsequently interpreted using subgroup-specific representative values. Short-term agreement between simulated tumor extent and postoperative follow-up MRI was assessed within the available cohort. Main Results: The proposed framework improved agreement between simulated and observed tumor extent within the studied cohort and demonstrated biologically coherent behavior across molecular subgroups. The pathology-informed proliferation term allowed the model to reflect differences in tumor aggressiveness associated with Ki-67 expression and IDH-1 status. In addition, the model generated spatial representations of tumor infiltration extending beyond the visible margins detected by routine MRI, highlighting regions of potential microscopic spread that are not directly observable on standard imaging. Significance: This study presents an exploratory step toward linking routinely acquired pathological biomarkers with physics-based glioblastoma growth modeling, by using standard-of-care MRI and immunohistochemical data, the proposed framework provides a clinically accessible tumor-growth prior that may support future treatment-response modeling, survival analysis, and individualized planning. Further validation in larger independent cohorts and extension to three-dimensional modeling are required before prospective clinical application.

4 April 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MIMaryam Iranpour
Maryam Iranpour
FBFatemeh Boroumandfar
Fatemeh Boroumandfar
SFSadra Faramarzpour
Sadra Faramarzpour
MFMahsa Faramarzpour
Mahsa Faramarzpour
Background: Abnormal uterine bleeding (AUB) is a common condition among women of reproductive age. This symptom is characterized by irregularities in menstrual frequency, duration, and volume. Early detection and management of AUB are crucial for improving women’s health outcomes. This study aimed to assess the pathological findings of diagnostic curettage (D&C) in women of childbearing age with AUB at Afzalipour Hospital, Kerman, Iran. Methods: This cross-sectional study included 1053 women aged 15–49 who underwent D&C for AUB between 2020 and 2021. Patient demographics and histopathological findings were gathered retrospectively from the pathology reports. Statistical analysis was conducted using the Kruskal–Wallis test to evaluate the relationship between pathological findings and patient age. Results: Among the participants, 99.3% of the findings were benign, with pregnancy-related issues, normal-phase lesions, and hormone imbalances being the most common diagnoses, respectively. The average ages for the normal phase and pregnancy-related issues were significantly lower than those for malignancies, which were predominantly found in older women (average age of 45 years). Statistical analysis revealed significant age-related differences in the types of pathologies ( P -value <0.001). Conclusion: This study suggests that benign conditions are the primary cause of AUB in younger women, whereas the risk of malignancy increases with age. These findings underscore the importance of targeted diagnostic approaches, timely interventions, and appropriate management, particularly in resource-limited countries, such as Iran.